About the job
Join Axsome Therapeutics, a pioneering biopharmaceutical company at the forefront of innovating treatments for central nervous system (CNS) disorders. We are committed to bridging critical gaps in medical care by developing unique therapies that leverage novel mechanisms of action, significantly improving patient outcomes. Our extensive neuroscience portfolio features FDA-approved solutions for major depressive disorder, excessive daytime sleepiness linked to narcolepsy and obstructive sleep apnea, as well as migraines. Additionally, we are advancing multiple late-stage development programs targeting a diverse array of severe neurological and psychiatric conditions affecting over 150 million individuals in the United States. Together, we strive to tackle some of the most significant challenges of the brain, enabling patients and their families to thrive.

